Study for Safety , immunogenicity and efficacy of intramuscular administration of Haemophilus Influenzae type b conjugate vaccine manufactured by Masoondarou Co. (MAS-HibVAC) in 50 children and compare with foreign sample -
Phase of Trial: Phase III
Latest Information Update: 14 Sep 2016
At a glance
- Drugs Hib vaccine conjugate (Primary)
- Indications Haemophilus infections
- Focus Adverse reactions; Pharmacodynamics; Registrational; Therapeutic Use
- Sponsors Masoondarou Biopharma
- 04 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by Iranian Registry of Clinical Trials.
- 09 May 2012 Status changed from not yet recruiting to recruiting as reported by Iranian Registry of Clinical Trials.
- 19 Apr 2012 New trial record